Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4369-4373

  Roumenina, Lubka T ^a,b,c   Sène, Damien ^b,d   Radanova, Maria ^e   Blouin, Jacques ^f   Halbwachs Mecarelli, Lise ^c,g   Dragon Durey, Marie Agnes ^a,b,c,f   Fridman, Wolf H ^a,b,c,f   Fremeaux Bacchi, Veronique ^a,f  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; METHOTREXATE; PENTRAXIN; PREDNISONE; STEROID; VALPROIC ACID;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BINDING SITE; CASE REPORT; CELL METABOLISM; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPLEX FORMATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; FUNCTIONAL DISEASE; GENE MUTATION; HOMOZYGOSITY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; MALE; MEDICAL HISTORY; MIXED INFECTION; NEUROLOGIC DISEASE; OPSONIZATION; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION;

ADULT; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; DNA MUTATIONAL ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POINT MUTATION; SELF TOLERANCE;

EID: 80054736581     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101749     Document Type: Article

References (39)

1. Ricklin, D., G. Hajishengallis, K. Yang, and J. D. Lambris. 2010. Complement: a key systemfor immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
2. Gaboriaud, C., N. M. Thielens, L. A. Gregory, V. Rossi, J. C. Fontecilla-Camps, and G. J. Arlaud. 2004. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 25: 368-373. (Pubitemid 38780953)
3. Kishore, U., S. K. Gupta, M. V. Perdikoulis, M. S. Kojouharova, B. C. Urban, and K. B. Reid. 2003. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J. Immunol. 171: 812-820. (Pubitemid 36871392)
4. Roumenina L. T., K. T. Popov, S. V. Bureeva, M. Kojouharova, M. Gadjeva, S. Rabheru, R. Thakrar, A. Kaplun, and U. Kishore. 2008. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim. Biophys. Acta 1784: 1271-1276.
5. Roumenina, L. T., M. M. Ruseva, A. Zlatarova, R. Ghai, M. Kolev, N. Olova, M. Gadjeva, A. Agrawal, B. Bottazzi, A. Mantovani, et al. 2006. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry 45: 4093-4104.
6. McGrath, F. D., M. C. Brouwer, G. J. Arlaud, M. R. Daha, C. E. Hack, and A. Roos. 2006. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176: 2950-2957.
7. Bally, I., V. Rossi, T. Lunardi, N. M. Thielens, C. Gaboriaud, and G. J. Arlaud. 2009. Identification of the C1q-binding Sites of Human C1r and C1s: a refined three-dimensional model of the C1 complex of complement. J. Biol. Chem. 284: 19340-19348.
8. Frémeaux-Bacchi, V., L. Weiss, C. Demouchy, J. Blouin, and M. D. Kazatchkine. 1996. Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5: 216-220. (Pubitemid 26197480)
9. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-2756.
10. Roumenina, L. T., M. Jablonski, C. Hue, J. Blouin, J. D. Dimitrov, M. A. Dragon-Durey, M. Cayla, W. H. Fridman, M. A. Macher, D. Ribes, et al. 2009. Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 114: 2837-2845.
11. Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344: 1140-1144.
12. Fraser, D. A., A. K. Laust, E. L. Nelson, and A. J. Tenner. 2009. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J. Immunol. 183: 6175-6185.
13. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59. (Pubitemid 28242023)
14. Pickering, M. C., M. Botto, P. R. Taylor, P. J. Lachmann, and M. J. Walport. 2000. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv. Immunol. 76: 227-324.
15. Brier, S., D. Pflieger, M. Le Mignon, I. Bally, C. Gaboriaud, G. J. Arlaud, and R. Daniel. 2010. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex. J. Biol. Chem. 285: 32251-32263.
16. Fraser, D. A., K. Pisalyaput, and A. J. Tenner. 2010. C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production. J. Neurochem. 112: 733-743.
17. Korb, L. C., and J. M. Ahearn. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158: 4525-4528. (Pubitemid 127483768)
18. Navratil, J. S., S. C. Watkins, J. J. Wisnieski, and J. M. Ahearn. 2001. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J. Immunol. 166: 3231-3239. (Pubitemid 33117322)
19. Nauta, A. J., L. A. Trouw, M. R. Daha, O. Tijsma, R. Nieuwland, W. J. Schwaeble, A. R. Gingras, A. Mantovani, E. C. Hack, and A. Roos. 2002. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 32: 1726-1736. (Pubitemid 34679160)
20. Païdassi, H., P. Tacnet-Delorme, T. Lunardi, G. J. Arlaud, N. M. Thielens, and P. Frachet. 2008. The lectin-like activity of human C1q and its implication in DNA and apoptotic cell recognition. FEBS Lett. 582: 3111-3116.
21. Païdassi, H., P. Tacnet-Delorme, V. Garlatti, C. Darnault, B. Ghebrehiwet, C. Gaboriaud, G. J. Arlaud, and P. Frachet. 2008. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J. Immunol. 180: 2329-2338.
22. Garlatti, V., A. Chouquet, T. Lunardi, R. Vivès, H. Pädassi, H. Lortat-Jacob, N. M. Thielens, G. J. Arlaud, and C. Gaboriaud. 2010. Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain. J. Immunol. 185: 808-812.
23. Mihlan, M., S. Stippa, M. Józsi, and P. F. Zipfel. 2009. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H. Cell Death Differ. 16: 1630-1640.
24. Litvack, M. L., and N. Palaniyar. 2010. Review: Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. Innate Immun. 16: 191-200.
25. Kravitz, M. S., and Y. Shoenfeld. 2006. Autoimmunity to protective molecules: is it the perpetuum mobile (vicious cycle) of autoimmune rheumatic diseases? Nat. Clin. Pract. Rheumatol. 2: 481-490. (Pubitemid 44340424)
26. Kravitz, M. S., M. Pitashny, and Y. Shoenfeld. 2005. Protective molecules - C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannosebinding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity. J. Clin. Immunol. 25: 582-591. (Pubitemid 43011749)
27. Chen, Y., Y. B. Park, E. Patel, and G. J. Silverman. 2009. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182: 6031-6043.
28. Zlatarova, A. S., M. Rouseva, L. T. Roumenina, M. Gadjeva, M. Kolev, I. Dobrev, N. Olova, R. Ghai, J. C. Jensenius, K. B. Reid, et al. 2006. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q. Biochemistry 45: 9979-9988. (Pubitemid 44257392)
29. Roumenina, L., S. Bureeva, A. Kantardjiev, D. Karlinsky, J. E. Andia-Pravdivy, R. Sim, A. Kaplun, M. Popov, U. Kishore, and B. Atanasov. 2007. Complement C1q-target proteins recognition is inhibited by electric moment effectors. J. Mol. Recognit. 20: 405-415.
30. Roumenina, L. T., M. Radanova, B. P. Atanasov, K. T. Popov, S. V. Kaveri, S. Lacroix-Desmazes, V. Frémeaux-Bacchi, and J. D. Dimitrov. 2011. Heme interacts with c1q and inhibits the classical complement pathway. J. Biol. Chem. 286: 16459-16469.
31. Castellano, G., A. M. Woltman, N. Schlagwein, W. Xu, F. P. Schena, M. R. Daha, and C. van Kooten. 2007. Immune modulation of human dendritic cells by complement. Eur. J. Immunol. 37: 2803-2811. (Pubitemid 47578300)
32. Lacroix, M., C. Dumestre-Pérard, G. Schoehn, G. Houen, J. Y. Cesbron, G. J. Arlaud, and N. M. Thielens. 2009. Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J. Immunol. 182: 456-465.
33. Rahman, A., and D. A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358: 929-939. (Pubitemid 351397092)
34. Lipsker, D., and G. Hauptmann. 2010. Cutaneous manifestations of complement deficiencies. Lupus 19: 1096-1106.
35. Bowness, P., K. A. Davies, P. J. Norsworthy, P. Athanassiou, J. Taylor- Wiedeman, L. K. Borysiewicz, P. A. Meyer, and M. J. Walport. 1994. Hereditary C1q deficiency and systemic lupus erythematosus. QJM 87: 455-464. (Pubitemid 24243465)
36. Stevens, B., N. J. Allen, L. E. Vazquez, G. R. Howell, K. S. Christopherson, N. Nouri, K. D. Micheva, A. K. Mehalow, A. D. Huberman, B. Stafford, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-1178. (Pubitemid 350235022)
37. Fourgeaud, L., and L. M. Boulanger. 2007. Synapse remodeling, compliments of the complement system. Cell 131: 1034-1036. (Pubitemid 350245399)
38. Chu, Y., X. Jin, I. Parada, A. Pesic, B. Stevens, B. Barres, and D. A. Prince. 2010. Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc. Natl. Acad. Sci. USA 107: 7975-7980.
39. Tsuge, I., Y. Kondo, Y. Nakajima, N. Nakagawa, K. Imai, S. Nonoyama, K. Oshima, O. Ohara, M. Hatanaka, E. Kitano, et al. 2010. Hyper IgM syndrome and complement Clq deficiency in an individual with systemic lupus erythematosus-like disease. Clin. Exp. Rheumatol. 28: 558-560.